What's Happening?

Sibel Health has received FDA 510(k) clearance for its ANNE® Maternal platform, marking a significant advancement in maternal-fetal monitoring technology. The platform is the first of its kind to offer fully wireless, comprehensive monitoring of maternal and fetal health, utilizing advanced wearable sensor technology. This system allows for continuous monitoring of vital signs such as heart rate, respiratory rate, blood oxygen saturation, and skin temperature, alongside fetal heart rate and uterine contraction detection. The clearance comes at a critical time, as the U.S. faces a high maternal mortality rate, with ANNE® Maternal aiming to address this by providing continuous monitoring in both intrapartum and postpartum settings.

Why It's Important?

The FDA clearance of ANNE® Maternal is a pivotal development in addressing the maternal health crisis in the United States, where the maternal mortality rate is notably high compared to other high-income nations. This platform offers a solution by enabling continuous and comprehensive monitoring, which has been lacking in labor and delivery settings. The technology not only meets rigorous clinical standards but is also designed for deployment in resource-limited settings globally, supported by a $17.5 million grant from the Gates Foundation. This dual-market approach could significantly impact maternal health outcomes both domestically and internationally.

What's Next?

Following the FDA clearance, Sibel Health plans to expand the deployment of ANNE® Maternal across various countries, including India, Pakistan, Nigeria, and Rwanda, in collaboration with global health research units. The company is also set to receive additional funding to develop AI-powered features for the platform, aimed at enhancing its capabilities in low-resource settings. These developments are expected to further integrate into future product releases, potentially setting a new standard for maternal monitoring worldwide.

AI Generated Content

For the benefit of users - Parts of this article may include content generated using AI tools. Our teams are making active and commercially reasonable efforts to moderate all AI generated content. Our moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. We encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. We maintain that all AI generated content on our platform is for entertainment purposes only. To know more about how we use AI, you can write to us at

Close AI Generated Content